1. Home
  2. URGN vs CENTA Comparison

URGN vs CENTA Comparison

Compare URGN & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

N/A

Current Price

$43.39

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Logo Central Garden & Pet Company Nonvoting

CENTA

Central Garden & Pet Company Nonvoting

N/A

Current Price

$36.31

Market Cap

2.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
URGN
CENTA
Founded
2004
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.3B
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
URGN
CENTA
Price
$43.39
$36.31
Analyst Decision
Strong Buy
Hold
Analyst Count
7
4
Target Price
$29.29
$36.75
AVG Volume (30 Days)
985.0K
295.4K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.41
EPS
N/A
2.84
Revenue
$1,128,000.00
$3,129,100,000.00
Revenue This Year
$129.09
$1.60
Revenue Next Year
$70.96
$2.04
P/E Ratio
N/A
$13.10
Revenue Growth
N/A
N/A
52 Week Low
$15.86
$25.97
52 Week High
$50.81
$40.80

Technical Indicators

Market Signals
Indicator
URGN
CENTA
Relative Strength Index (RSI) 45.28 37.34
Support Level $18.25 $33.34
Resistance Level $43.93 $37.71
Average True Range (ATR) 1.82 0.88
MACD -0.90 -0.20
Stochastic Oscillator 14.81 17.43

Price Performance

Historical Comparison
URGN
CENTA

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

Share on Social Networks: